TTD | Drug: D04ETV

Drug General Information
Drug ID	D04ETV
Former ID	DIB000407
Drug Name	Nemonaxacin
Indication	Methicillin-resistant staphylococcus aureus infection [ICD10:B95.62]		Phase 3	[524857]
Company	Warner Chilcott plc
Target and Pathway
Target(s)	Topoisomerase IV	Target Info	Modulator
References
Ref 524857	ClinicalTrials.gov (NCT02205112) A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP. U.S. National Institutes of Health.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information